8283:TSEPaltac Corporation Analysis
Data as of 2026-03-17 - not real-time
¥4,693.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Paltac Corp (8283.T) is trading at ¥4,693, comfortably above its DCF‑derived fair value of ¥4,425, suggesting a modest premium. The stock sits between its 20‑day SMA (¥4,841) and 50‑day SMA (¥4,892), indicating a short‑term pull‑back from recent averages. Momentum indicators are mixed: the 14‑day RSI at 41 points to neither overbought nor oversold conditions, while the MACD line remains below the signal line, delivering a bearish signal. Technical support sits at ¥4,565 and resistance at ¥5,067, placing the current price nearer the support zone. Volatility over the past 30 days is elevated at roughly 23 %, yet the beta of 0.22 underscores a muted reaction to broader market swings. On the fundamentals side, the company posts a solid dividend yield of 2.71 % with a payout ratio of 31 %, backed by ample cash and zero debt.
Revenue growth of 4.8 % and a price‑to‑book ratio just below 1 (0.96) reinforce a value‑oriented profile. The low price‑to‑sales multiple (0.23) and a PE of 13.1 further highlight relative cheapness despite the slight premium to DCF. The “Extreme Greed” reading on the fear‑and‑greed index (81.1) signals strong market appetite, which could pressure the stock higher in the near term. However, thin operating margins (≈2.5 %) and modest ROE (7.5 %) temper expectations for rapid earnings acceleration. The defensive consumer sector and the company’s debt‑free balance sheet reduce regulatory and financial headwinds. Overall, the blend of attractive yield, defensive positioning, and near‑term technical weakness points to a cautious but potentially rewarding outlook.
Revenue growth of 4.8 % and a price‑to‑book ratio just below 1 (0.96) reinforce a value‑oriented profile. The low price‑to‑sales multiple (0.23) and a PE of 13.1 further highlight relative cheapness despite the slight premium to DCF. The “Extreme Greed” reading on the fear‑and‑greed index (81.1) signals strong market appetite, which could pressure the stock higher in the near term. However, thin operating margins (≈2.5 %) and modest ROE (7.5 %) temper expectations for rapid earnings acceleration. The defensive consumer sector and the company’s debt‑free balance sheet reduce regulatory and financial headwinds. Overall, the blend of attractive yield, defensive positioning, and near‑term technical weakness points to a cautious but potentially rewarding outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD signal
- Price near technical support
- Attractive dividend yield providing downside cushion
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Stable cash flow and zero debt
- Defensive consumer sector resilience
- Valuation metrics near fair value
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend with low payout ratio
- Low financial leverage and strong balance sheet
- Defensive positioning in household & personal products
Key Metrics & Analysis
Financial Health
Revenue Growth4.80%
Profit Margin1.78%
P/E Ratio13.1
ROE7.49%
ROA3.22%
P/B Ratio1.0
Op. Cash Flow¥19.4B
Free Cash Flow¥12.2B
Technical Analysis
TrendNeutral
RSI41.0
Support¥4,565.00
Resistance¥5,067.00
MA 20¥4,841.20
MA 50¥4,891.68
MA 200¥4,558.84
MACDBearish
VolumeIncreasing
Fear & Greed Index81.09
Valuation
Fair Value¥4,425.85
Target Price¥5,145.00
Upside/Downside9.63%
GradeFair
TypeValue
Dividend Yield2.71%
Risk Assessment
Beta0.22
Volatility23.18%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.